ABSTRACTpseudotumor in the clinic is relative low, delayed diagnosis or misdiagnosis may cause delays in treatment of these patients and subsequently may lead to physical and mental damage (14). The differential diagnosis of demyelinating pseudotumor and brain tumors, especially of low-grade astrocytomas, should arouse more attention to exclude the possibility of a demyelinating process. Despite this, only few reported cases of intracranial demyelinating pseudotumor are known in the literature. In this case report, we present the diagnosis and treatment of a demyelinating pseudotumor patient who was misdiagnosed with astrocytoma.
█ CASE REPORTA female 40-year-old patient was hospitalized due to a progressive disability of the left limb that severely increased over one week. The patient did not have a recent history █ INTRODUCTION D emyelinating pseudotumor of the brain, also called tumor-like demyelinating lesions (TDLs) or inflammatory demyelinating pseudotumor (IDP), is a rare inflammatory demyelinating disease of the central nervous system (CNS) (3,4,7,8). The exact etiology of demyelinating pseudotumor is unclear, however it may associate with multiple sclerosis (MS) (5). Based on the clinical presentation and computed tomography (CT) and magnetic resonance imaging (MRI) findings, it is difficult to distinguish between brain tumors, abscesses and demyelinating pseudotumors (13). Unlike brain tumors, demyelinating pseudotumors respond well to steroid hormones (6). Therefore, a reliable distinction between brain tumors and intracranial demyelinating pseudotumors is important for a targeted therapy. Although the incidence of demyelinating Demyelinating pseudotumor is a rare inflammatory demyelinating disease of the central nervous system (CNS) that has a similar clinical presentation and computed tomography (CT) and magnetic resonance imaging (MRI) imaging findings as brain tumors or abscesses. Unlike brain tumors, demyelinating pseudotumors respond well to steroid hormones. There are only a few reported cases of intracranial demyelinating pseudotumors in the literature. In this case report, we present the diagnosis and treatment of demyelinating pseudotumor in a patient whose condition was initially misdiagnosed as an astrocytoma. Based on the literature and our case, we formulated an outline for the differential diagnosis of demyelinating pseudotumor and astrocytoma. A timely and correct diagnosis of demyelinating pseudotumor would avoid blind surgery, radiotherapy and chemotherapy, which are used to treat brain tumors.